Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 0.75 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (S)-Proxyphylline SCHEMBL35570 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| Dyphylline SCHEMBL13724353 | 0.92 | LMNA (0.90) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL13944619 | 0.90 | LMNA (0.81) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL683878 | 0.89 | LMNA (0.80) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL10859640 | 0.89 | LMNA (0.80) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| Isbufylline SCHEMBL678978 | 0.88 | LMNA (0.78) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL20161775 | 0.87 | LMNA (0.77) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL11830512 | 0.87 | LMNA (0.77) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL11123833 | 0.86 | LMNA (0.75) | LMNASMN1; SMN2POLBADORA2BMAPT | |
| SCHEMBL17486883 | 0.86 | LMNA (0.76) | LMNASMN1; SMN2POLBADORA2BMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 28952 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017878-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | CHRONIC AIRWAY THERAPEUTICS LTD (AU) | 2025-01-16 | — | — | US | claimed |
| US-20250006331-A1 | QUANTITATIVE SYSTEMS PHARMACOLOGY METHODS FOR IDENTIFYING THERAPEUTICS FOR DISEASE STATES | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2025-01-02 | — | — | US | claimed |
| WO-2024189434-A1 | USE OF NADOLOL TO TREAT PULMONARY SYMPTOMS ASSOCIATED WITH INFECTIONS WITH SARS-CoV-2 | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2024-09-19 | — | — | WO | claimed |
| WO-2024141752-A1 | MAGNETICALLY GEARED SYSTEMS AND METHODS | MAGNOMATICS LIMITED (GB) | 2024-07-04 | — | — | WO | claimed |
| CN-117919253-A | Application of xanthine compound in preparation of medicines for activating primordial follicles | 华南理工大学 | 2024-04-26 | — | — | CN | claimed |
| US-11966042-B2 | Augmented reality display units and augmented reality headsets comprising the same | ADLENS LTD. (GB) | 2024-04-23 | — | — | US | claimed |
| CN-117691920-B | Automatic control method for servo motor | 成都航空职业技术学院 | 2024-04-12 | — | — | CN | claimed |
| CN-112288679-B | Interactive extraction method and system for defect area of automobile hub X-ray image | 中北大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117531218-A | Pressure reduction control device for improving carbon dioxide yield | 山西潞安煤基合成油有限公司 | 2024-02-09 | — | — | CN | claimed |
| EP-4304717-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | Chronic Airway Therapeutics Limited (AU) | 2024-01-17 | — | — | EP | claimed |
| EP-0213083-A2 | Controlled release tablet | Zyma SA (CH) | 1987-03-04 | — | — | EP | claimed |
| EP-0193599-A1 | XANTHINE DERIVATIVE PEST CONTROL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 1986-09-10 | — | — | EP | claimed |
| US-4581359-A | FOR BRONCHOPULMONARY INSUFFUCIENCY | THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1986-04-08 | — | — | US | claimed |
| WO-1986001724-A1 | XANTHINE DERIVATIVE PEST CONTROL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 1986-03-27 | — | — | WO | claimed |
| US-4499170-A | Lithographic plates and photoresists having stabilized photosensitive diazo resin with theophylline derivative | RICHARDSON GRAPHICS COMPANY (US) | 1985-02-12 | — | — | US | claimed |
| US-4425345-A | XANTHINE SOLUBILIZER | SMITH AND NEPHEW ASSOCIATED COMPANIES LIMITED (GB) | 1984-01-10 | — | — | US | claimed |
| US-4425346-A | ANTIGLAUCOMA AGENTS | SMITH AND NEPHEW ASSOCIATED COMPANIES LIMITED (GB) | 1984-01-10 | — | — | US | claimed |
| EP-0045617-A2 | Pharmaceutical composition | Smith and Nephew Associated Companies p.l.c. (GB) | 1982-02-10 | — | — | EP | claimed |
| US-4117132-A | PROCESS FOR THE PRODUCTION OF STABILIZED PURE THEOPHYLLINE IN NEUTRAL, AQUEOUS SOLUTION | DR. ADOLF SEEBACH AG (CH) | 1978-09-26 | — | — | US | claimed |
| US-3986852-A | ROTARY COOLING AND HEATING APPARATUS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-10-19 | — | — | US | claimed |